Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma

Human Gene Therapy

Volumn 8, Issue 3, 1997, Pages 349-358

  Qian, Cheng ^a   Idoate, Miguel ^a   Bilbao, Roberto ^a   Sangro, Bruno ^a   Bruña, Oscar ^a   Vázquez, Jesús ^a   Prieto, Jesús ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BETA GALACTOSIDASE; CYCLINE; DIETHYLNITROSAMINE; DRUG METABOLITE; GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL DESTRUCTION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIZATION; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER PARENCHYMA; LIVER TOXICITY; MALE; MORTALITY; NONHUMAN; RAT; REPORTER GENE; RISK ASSESSMENT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0030798508     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.3-349     Document Type: Article

References (46)

1. ANDERSON, W.F. (1994). Gene therapy for cancer. Hum. Gene Ther. 5, 1-2.
2. ARBUTHNOT, P.B., BRALET, M., JOSSIC, C.L., DEDIEU, J., PERRICAUDET, M., BRfCHOT, C., and FERRY, N. (1996). In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum. Gene Ther. 7, 1503-1514.
3. BAO, J., ZHANG, W., and KUO, M.T. (1996). Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum. Gene Ther. 7, 355-365.
4. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of antitumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
5. BARBASON, H., and BETZ, E.H. (1981a). Liver cell control after discontinuation of DENA feeding in hepatocarcinogenesis. Eur. J. Cancer 17, 149-154.
6. BARBASON, H., and BETZ, E.H. (1981b). Proliferation of preneoplastic lesions after discontinuation of chronic DENA feeding in the development of hepatoma in rat. Br. J. Cancer 44, 561-566.
7. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vivo evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
8. BREEDIS, C., and YOUNG, G. (1954). The blood supply of neoplasmas in the liver. Am. J. Pathol. 30, 969-985.
9. BROWN, T. (1994). Analysis of DNA sequences. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds. (John Wiley & Sons, Inc.) pp. 10.6.1-10.6.27.
10. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028.
11. CHEN, S., SHINE, H.D., GOODMAN, J.C., GROSSMANN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
12. COLOMBO, M. (1992). Hepatocellular carcinoma. J. Hepatol. 15, 225-236.
13. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
14. DEAL, F.D., RICHARDSON, F.C., and SWENBERG, J.A. (1989). Dose response of hepatocyte replication in rats following continuous exposure to diethylnitrosamine. Cancer Res. 49, 6985-6988.
15. FACCIOLI, S., CHIECO, P., GRAMANTIERI, L., STECCA, B.A., and BOLONDI, L. (1996). Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. Modern Pathol. 9, 120-125.
16. FARBER, W., and SARMA, D.S.R. (1987). Hepatocarcinogenesis: A dynamic cellular perspective. Lab. Invest. 56, 4-22.
17. FARMER, D.G., and BUSUTTIL, R.W. (1994). The role of multimodal therapy in the treatment of hepatocellular carcinoma. Cancer 73, 2669-2670.
18. FREEMAN, S.M., ABBOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KOEPLIN, D.S., MOOLTEN, F.L., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
19. GAGANDEEP, S., BREW, R., GREEN, B., CHRISTMAS, S.E., KLATZMANN, D., POSTON, G.J., and KINSELLA, A.R. (1996). Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect." Cancer Gene Ther. 3, 83-88.
20. GORE, M.E., and COLLINS, M.K. (1994). Gene therapy for cancer. Eur. J. Cancer. 30A, 1047-1049.
21. GUTIERREZ, A.A., LEMOINE, N.R., and SIKORA, K. (1992). Gene therapy for cancer. The Lancet 339, 715-721.
22. HWANG, H.C., SMYTHE, W.R., ELSHAMI, A.A., KUCHARCZUK, J.C., AMIN, K.M., WILLIAMS, J.P., LITZKY, L.A., KAISER, L.R., and ALBELDA, S.M. (1995). Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am. J. Respir. Cell. Mol. Biol. 13, 7-16.
23. IDO, A., NAKATA, K., KATO, Y., NAKAO, K., MURATA, K., FUJITA, M., ISHU, N., TAMAOKI, T., SHIKU, H., and NAGATAKI, S. (1995). Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of a human a-fetoprotein gene promoter. Cancer Res. 55, 3105-3109.
24. KANEKO, S., HALLENBECK, P., KOTANI, T., NAKABAYASHI, H., MCGARRTTY, G., TAMAOKI, T., ANDERSON, W.F., and CHIANG, Y.L. (1995). Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res. 55, 5283-5287.
25. KURIYAMA, S., NAKATANI, T., MASUI, K., SAKAMOTO, T., TOMINAGA, K., YOSHIKAWA, M., FUKUI, H., IKENAKA, K., and TSUJII, T. (1995). Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 22, 1838-1846.
26. MACRI, P., and GORDON, J.W. (1994). Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an a-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir. Hum. Gene Ther. 5, 175-182.
27. MOOLTEN, F.L. (1994). Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther. 1, 279-287.
28. MOOLTEN, F.L., and WELLS, J.M. (1990). Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst. 82, 297-300.
29. NAKAJIMA, T., KAGAWA, K., UEDA, K., OHKAWARA, T., KIMURA, H., KAKUSUI, M., DEGUCHI, T., OKANOUE, T., KASHIMA, K., and ASHIHARA, T. (1994). Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues. J. Gastroenterol. 29, 450-454.
30. NG, I.O., PATH, M.R.C., LAI, E.C.S., FAN, S.T., NG, M., CHAN, A.S.Y., and SO, M.K.P. (1994). Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 73, 2268-2274.
31. PETO, R., GRAY, R., BRANTOM, P., and GRASSO, P. (1991). Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res. 51, 6452-6459.
32. QIAN, C., BILBAO, R., BRUÑA, O., and PRIETO, J. (1995). Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology 22, 118-123.
33. RABES, H.M., and SZYMKOWIAK, R. (1979). Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis. Cancer Res. 39, 1298-1304.
34. RAJEWSKY, M.F. (1967). Changes in DNA synthesis and cell proliferation during hepatocarcinogenesis by diethylnitrosamine. Eur. J. Cancer 3, 335-342.
35. RAJEWSKY, M.F., DAUBER, W., and FRANKENBERG, H. (1966). Liver carcinogenesis by diethylnitrosamine in the rat. Science 152, 83-85.
36. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
37. SHEWACH, D.S., ZERBE, L.K., HUGHES, T.L., ROESSLER, B.J., BREAKEFIELD, X.O., and DAVIDSON, B.L. (1994). Enhanced cytotoxicity of antiviral drugs mediated by adenovirus directed transfer of the herpes simplex virus thymidine kinase gene in rat glioma cells. Cancer Gene Ther. 1, 107-112.
38. SMYTHE, W.R., HWANG, H.C., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELD, S.M. (1994). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms an effective in vitro drug sensitization system. Cancer Res. 54, 2055-2059.
39. TANIGUCHI, H., DAIDOH, T., SHIOAKI, Y., and TAKAHASHI, T. (1993). Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling. Cancer 71, 50-55.
40. UNSAL, H., YAKICIER, C., MARCAIS, C., KEW, M., VOLKMANN, M., ZENTGRAF, H., ISSELLBACHER, K.J., and OZTURK, M. (1994). Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 91, 822-826.
41. VENOOK, A.P. (1994). Treatment of hepatocellular carcinoma: too many options?. J. Clin. Oncol. 12, 1323-1334.
42. VETTER, D., WENGER, J., BERGIER, J., DOFFOEL, M., and BOCKEL, R. (1990). Transcatheter oily chemoembolization in the management of advanced hepatocelular carcinoma in cirrhosis: results of a western comparative study in 60 patients. Hepatology 13, 427-433.
43. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H., and HART, I.R. (1994). Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res. 53, 3860-3864.
44. WILLS, K.N., HUANG, W., HARRIS, M.P., MACHEMER, T., MANEVAL, D.C., and GREGORY, R.J. (1995). Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther. 2, 191-197.
45. YANG, Y., NUNEZ, F.A., BERENCSI, K., FURTH, E.E., GÖNCZÖL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
46. YANG, Y., XIANG, Z., ERTL, H.C.J., and WILSON, J.M. (1995). Upregulation of class I major histocompatibility complex antigens by interferon is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92, 7257-7261.